Kimi K2.6's impressive new capabilities could redefine how developers approach complex, multi-step engineering workflows.
Many new gene therapy treatments aren’t as profitable as predicted. But the reasons why don’t quite fit Goldman Sachs’ ...
How did a nine-year-old game about competitive pottery get resurrected as Psychonauts 2 developer Double Fine ’s next game?